Nanotein’s NanoSpark® reagents enhance cell activation and expansion in cell therapy manufacturing Exclusive global distribution agreement for NanoSpark® activation products Joint development of new solutions for cell and gene therapy markets Sartorius Stedim Biotech enters into minority shareholding Sartorius Stedim Biotech, a leading partner to the biopharmaceutical industry, and Nanotein Technologies, a developer of next-generation […]
San Diego, CA – Quantum Design (QD) is proud to announce a new strategic distribution‑ agreement‑ with illumion Ltd., pioneers of charge photometry — a benchtop imaging technique that reveals real time, particle level electrochemical and morphological changes in batteries. Leveraging Quantum Design’s deep market‑ knowledge and scientific instrumentation expertise, illumion aims to accelerate the adoption […]
Aiming to Commercialize Industry-first Continuous Electroporation Technology TOKYO and KYOTO – FUJIFILM Corporation (President and CEO, Representative Director: Teiichi Goto) and HORIBA, Ltd. (President: Masayuki Adachi) today announced the co-development of a novel gene delivery system that significantly enhances productivity in the manufacture of gene therapy products. Fujifilm has developed the industry’s first*1 continuous electroporation […]
New adventitious viral agent (AVA) detection test offers rapid, sensitive, and affordable viral screening for biomanufacturers ViruSure, a global leader in pathogen safety testing for biopharmaceuticals, and Oxford Nanopore Technologies, the company behind a new generation of molecular sensing technology based on nanopores, today announce the launch of the industry’s first Good Laboratory Practice (GLP) […]
ANN ARBOR, Mich. — Excellos, Lonza, and Akadeum Life Sciences today announce a new project aimed at redefining standards for cell therapy manufacturing by elevating the role of starting material quality. This project brings together leaders in donor cell characterization, automated manufacturing, and cell separation technology to explore how aligned, modular innovation can streamline workflows and […]
Strengthened collaboration to accelerate bioprocessing innovation and global distribution Culture Biosciences, an expert in cloud-connected bioreactor technology, and Cytiva, a Danaher company and a leader in the life sciences industry, have expanded their strategic collaboration to include both hardware commercialization and technology development. Building on an existing collaboration to offer a Cytiva 250mL consumable featuring […]
BOSTON and ROLLE, Switzerland — SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a global leader in data-driven medicine, today announced an expansion of its partnership with AstraZeneca (LSE/STO/Nasdaq: AZN). This new, multi-year collaboration will leverage SOPHiA GENETICS’s multimodal AI Factories to generate evidence on the efficacy, value, and real-world impact of therapies for certain types […]
MaxCyte’s Flow Electroporation® Technology will support non-viral gene editing in the manufacture of Anocca’s TCR-T cell therapies ROCKVILLE, Md. — MaxCyte, Inc., (Nasdaq: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell-based therapeutics, today announced the signing of a Strategic Platform License Agreement (SPL) […]
Shimadzu Corporation and Kyoto University (Yoshida-honmachi, Sakyo-ku, Kyoto-shi) have signed a comprehensive collaborative agreement with the objective of creating new business activities and innovation to contribute to solving social problems, and training global high-level human resources. In 2022, both parties signed a three-year comprehensive collaborative agreement with the objective of creating new business activities by […]
Allen Institute to employ Iterative Mapping, Nautilus’ single-molecule proteomics method, to investigate connection between tau protein and Alzheimer’s disease • Agreement links the organizations’ next-generation proteomics technology and neuroscience leadership to potentially unlock breakthrough therapeutics and biomarkers for neurodegenerative disease SEATTLE — Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering single-molecule proteome analysis, today announced […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
